Don't leave, TurboMice™ is coming to you!
Connecting to server... 0%
  • 4-Week Delivery: World’s fastest custom mouse model development.
  • TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
  • Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
  • Validated Quality: Guaranteed high precision and model viability.
Partners' Projects

Col1a2-CreERT2 Mouse Model

Category Tag
Strain Name

C57BL/6NMcl-Col1a2<sup>tm1(P2A-CreERT2)</sup>/MCL

Editing Type

Knock-In

Catalog No.

M02086

Strain Background

C57BL/6NMcl

Gene Name

Col1a2/collagen type I alpha 2 chain

Gene Synonyms

Cola2、Cola-2、Col1a-2

NCBI No.

12843 / MGI: 88468

Preserving Method

Live or Cryopreserved

  1. Fibroblast- and Mesenchymal-Cell-Specific Gene Knockout or Activation
  2. Fibroblast Lineage Tracing and Fate Mapping Research
  3. Research on Pulmonary, Hepatic, Renal, Cardiac, and Dermal Fibrosis
  4. Studies on Extracellular Matrix Deposition and Collagen Metabolism
  5. Research on Tissue Injury Repair, Wound Healing, and Regeneration
  6. Studies on Cancer-Associated Fibroblasts and the Tumor Microenvironment
  7. Research on Cardiovascular Remodeling and Perivascular Stromal Cells
  8. Studies on Bone, Cartilage, and Connective Tissue Diseases
By precisely inserting the P2A-CreERT2 expression cassette at the termination codon site at the end of the mouse Col1a2 coding sequence, the Col1a2-P2A-CreERT2 knock-in allele was successfully constructed. In this model, Col1a2 and CreERT2 are co-expressed from the same open reading frame; during translation, P2A induces ribosomal skipping, allowing the upstream Col1a2 protein and the downstream CreERT2 recombinase to form independent protein products without producing an intact Col1a2-CreERT2 fusion protein. It should be noted that the action of P2A is essentially a peptide bond skipping event during co-translation rather than classical protease-mediated post-translational cleavage, and both the upstream protein and downstream CreERT2 may retain a small number of P2A-related amino acid residues [1].
The Col1a2 gene encodes the type I collagen $\alpha2$ chain, which is an essential component of the type I collagen triple helix. Type I collagen is predominantly distributed in the extracellular matrix of skin, tendons, bone, heart, and other connective tissues, playing a crucial role in mechanical tissue support, cell adhesion, migration, and injury repair. Because Col1a2 regulatory elements drive gene expression in diverse fibroblast populations, the Col1a2-CreERT2 system has been utilized for fibroblast labeling, lineage tracing, and the study of fibrosis-related gene functions [2,3]. CreERT2 is an inducible recombinase composed of the Cre recombinase fused to a mutated estrogen receptor ligand-binding domain. In the absence of tamoxifen, CreERT2 remains predominantly cytoplasmic and unable to efficiently enter the nucleus, whereas tamoxifen administration promotes its nuclear translocation, thereby mediating loxP site recombination in mice carrying floxed alleles [4]. Consequently, when Col1a2-P2A-CreERT2 mice are crossed with floxed mice and treated with tamoxifen, temporally controlled conditional gene knockout, knock-in, or lineage tracing can be achieved in Col1a2-positive fibroblasts and their progeny. This provides a valuable genetic tool for investigating fibroblast functions, tissue injury repair, organ fibrosis, vascular remodeling, and tumor stromal responses across skin, heart, lungs, kidneys, and other tissues.
References
  1. Doronina VA, et al. Site-specific release of nascent chains from ribosomes at a sense codon. Mol Cell Biol. 2008;28:4227–4239.
  2. Zheng B, et al. Ligand-dependent genetic recombination in fibroblasts: a potentially powerful technique for investigating gene function in fibrosis. Am J Pathol. 2002;160:1609–1617.
  3. He L, et al. Preexisting endothelial cells mediate cardiac neovascularization after injury. J Clin Invest. 2017;127:2968–2981.
  4. Feil R, et al. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun. 1997;237:752–757.
  1. Col1a2-Expressing Cell Targeting: Driven by the endogenous Col1a2 promoter, Cre_ERT2_ expression targets fibroblasts and other mesenchymal cells expressing type I collagen, making it suitable for stromal cell studies across various tissues.
  2. Endogenous Expression Synchronization: Utilizing a P2A element allows Col1a2 and CreERT2 to be translated from the same transcript, ensuring that the spatiotemporal expression pattern of CreERT2 closely matches that of endogenous Col1a2.
  3. Inducible Spatiotemporal Control: CreERT2 requires tamoxifen induction to enter the nucleus and mediate LoxP site recombination. By regulating the timing and dosage of administration, gene knockout, activation, or cell labeling can be initiated at specific developmental stages or disease stages.
  4. Reduction of Unintended Developmental Recombination: Compared to constitutive Col1a2-Cre, the tamoxifen-inducible system minimizes permanent recombination caused by transient embryonic Col1a2 expression, making it better suited for studies involving adult mouse fibroblasts and mesenchymal cells.
  5. Preservation of Col1a2 Function: The P2A-CreERT2 cassette is inserted prior to the stop codon without replacing the main coding sequence of Col1a2, maintaining the expression and function of the endogenous type I collagen $\alpha2$ chain as much as possible while expressing CreERT2.

FAQ

Game-changing benefits?

While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.

•Free initial design proposal with zero obligations.​
•Request a free quote!

All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.

Days :
Hours :
Minutes :
Seconds

— Kickstart Your Research for 2026 Fall —

cKO Mouse Models
10% OFF

This website uses cookies

We use cookies to personalize content, provide social media features, and analyze our traffic. We also share information about your use of our site with our analytics partners. You can change your preferences at any time. For more information, please see our Privacy Policy Cookie Policy